Cite
Godier A, Dupont M, Desilles JP, et al. Successful Use of Recombinant Activated Factor VII to Reverse Ticagrelor-Induced Bleeding Risk: A Case Report. TH Open. 2018;2(3):e346-e349doi: 10.1055/s-0038-1672211.
Godier, A., Dupont, M., Desilles, J. P., Le Guerinel, C., Taylor, G., Perrin, M., Martin, A. C., & Gaussem, P. (2018). Successful Use of Recombinant Activated Factor VII to Reverse Ticagrelor-Induced Bleeding Risk: A Case Report. TH open : companion journal to thrombosis and haemostasis, 2(3), e346-e349. https://doi.org/10.1055/s-0038-1672211
Godier, Anne, et al. "Successful Use of Recombinant Activated Factor VII to Reverse Ticagrelor-Induced Bleeding Risk: A Case Report." TH open : companion journal to thrombosis and haemostasis vol. 2,3 (2018): e346-e349. doi: https://doi.org/10.1055/s-0038-1672211
Godier A, Dupont M, Desilles JP, Le Guerinel C, Taylor G, Perrin M, Martin AC, Gaussem P. Successful Use of Recombinant Activated Factor VII to Reverse Ticagrelor-Induced Bleeding Risk: A Case Report. TH Open. 2018 Sep 27;2(3):e346-e349. doi: 10.1055/s-0038-1672211. eCollection 2018 Jul. PMID: 31249959; PMCID: PMC6524896.
Copy
Download .nbib